Clinical trial
A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for…
NCT00191061 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191061 |
|---|---|
| Title | A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder |
| Official title | A Comparison of Duloxetine Dosing Strategies in The Treatment of Patients With Major Depression |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depressive Disorder |
| Intervention type | Drug |
| Interventions | duloxetine hydrochloride |
| Enrollment | 640 |
| Start date | Oct 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: